Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Rienk E. Jeeninga"'
Autor:
Johan L. Van Der Plas, Pauline Verdijk, Emilie M. J. Van Brummelen, Rienk E. Jeeninga, Meta Roestenberg, Jacobus Burggraaf, Ingrid M.C. Kamerling
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1322-1326 (2020)
One of the main challenges in early clinical research with respiratory syncytial virus (RSV) live-attenuated vaccines (LAVs) is to assess immunogenicity in healthy adults. Healthy adults will have preexisting levels of serum neutralizing antibodies t
Externí odkaz:
https://doaj.org/article/5b502c9fc390473da186d46f3123535f
Autor:
David C. Bibby, Michael Savanovic, Jinrong Zhang, Alessandro Torelli, Rienk E. Jeeninga, Luc Gagnon, Shannon L. Harris
Publikováno v:
mSphere, Vol 7, Iss 1 (2022)
ABSTRACT The hemagglutination inhibition (HI) assay is a prominent and commonly accepted method used to determine quantitative antibody titers for influenza virus. However, the reproducibility and consistency of this assay may be affected by several
Externí odkaz:
https://doaj.org/article/1fc9408ece164860a50c194832d9f5d3
Autor:
Matthijs R.A. Welkers, Hana A. Pawestri, Judy M. Fonville, Ondri D. Sampurno, Maarten Pater, Melle Holwerda, Alvin X. Han, Colin A. Russell, Rienk E. Jeeninga, Vivi Setiawaty, Menno D. de Jong, Dirk Eggink
Publikováno v:
Emerging Microbes and Infections, Vol 8, Iss 1, Pp 262-271 (2019)
ABSTRACTThe continuing pandemic threat posed by avian influenza A/H5N1 viruses calls for improved insights into their evolution during human infection. We performed whole genome deep sequencing of respiratory specimens from 44 H5N1-infected individua
Externí odkaz:
https://doaj.org/article/712f439daf674623b0a0add46fe1fbc9
Publikováno v:
Viruses, Vol 13, Iss 12, p 2461 (2021)
Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected individuals are currently being explored, including approaches based on CRISPR-Cas gene editing. Extinction of all infectious HIV provirus in infecte
Externí odkaz:
https://doaj.org/article/3b5585ef5a79455d909b0343ed011dbe
Autor:
Mai Quynh Le, Peter Horby, Annette Fox, Hien Tran Nguyen, Hang Khanh Le Nguyen, Phuong Mai Vu Hoang, Khanh Cong Nguyen, Menno D. de Jong, Rienk E. Jeeninga, H. Rogier van Doorn, Jeremy Farrar, Heiman F.L. Wertheim
Publikováno v:
Emerging Infectious Diseases, Vol 19, Iss 10, Pp 1674-1677 (2013)
Laboratory-confirmed cases of subclinical infection with avian influenza A(H5N1) virus in humans are rare, and the true number of these cases is unknown. We describe the identification of a laboratory-confirmed subclinical case in a woman during an i
Externí odkaz:
https://doaj.org/article/1e8ab0baa44b40cd8055a0748a618599
Publikováno v:
Journal of the Formosan Medical Association, Vol 108, Iss 7, Pp 523-525 (2009)
Externí odkaz:
https://doaj.org/article/ded8fe44ba9340ad9f5ee119f046bad7
Autor:
Le Van Tan, H. Rogier van Doorn, Ho Dang Trung Nghia, Tran Thi Hong Chau, Le Thi Phuong Tu, Michel de Vries, Marta Canuti, Martin Deijs, Maarten F. Jebbink, Stephen Baker, Juliet E. Bryant, Nguyen Thi Tham, Nguyen Thi Thuy Chinh BKrong, Maciej F. Boni, Tran Quoc Loi, Le Thi Phuong, Joost T. P. Verhoeven, Martin Crusat, Rienk E. Jeeninga, Constance Schultsz, Nguyen Van Vinh Chau, Tran Tinh Hien, Lia van der Hoek, Jeremy Farrar, Menno D. de Jong
Publikováno v:
mBio, Vol 4, Iss 3 (2013)
ABSTRACT Acute central nervous system (CNS) infections cause substantial morbidity and mortality, but the etiology remains unknown in a large proportion of cases. We identified and characterized the full genome of a novel cyclovirus (tentatively name
Externí odkaz:
https://doaj.org/article/9ae36551c31642fbb3ba20b9bf8474d6
T-cell acute lymphoblastic leukemia is a high-risk type of blood-cell cancer. We analyzed the possibility of developing virotherapy for T-cell acute lymphoblastic leukemia. Virotherapy is based on the exclusive replication of a virus in leukemic cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d40ca796644dbbbe455458151ffeb59
https://doi.org/10.1158/0008-5472.c.6494084
https://doi.org/10.1158/0008-5472.c.6494084
Supplementary Figure 1 from Construction of a Minimal HIV-1 Variant that Selectively Replicates in Leukemic Derived T-Cell Lines: Towards a New Virotherapy Approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c638e66abdc47947d3303dc5ddf8fd3
https://doi.org/10.1158/0008-5472.22364228
https://doi.org/10.1158/0008-5472.22364228
Autor:
Pauline Verdijk, Meta Roestenberg, Ingrid M C Kamerling, Emilie M. J. van Brummelen, Johan L. van der Plas, Rienk E. Jeeninga, Jacobus Burggraaf
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
One of the main challenges in early clinical research with respiratory syncytial virus (RSV) live-attenuated vaccines (LAVs) is to assess immunogenicity in healthy adults. Healthy adults will have preexisting levels of serum neutralizing antibodies t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f825e2f328fc5f276e2656aa59f70b3c
http://europepmc.org/articles/PMC7482755
http://europepmc.org/articles/PMC7482755